BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2873722)

  • 1. The pharmacological profile of a specific, safe, effective and non-sedative anti-allergic, astemizole.
    Niemegeers CJ; Awouters F; Janssen PA
    Agents Actions; 1986 Apr; 18(1-2):141-4. PubMed ID: 2873722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacology of astemizole (Hismanal) a non-sedating H1 antihistaminic].
    Niemegeers CJ
    Z Hautkr; 1985; 60 Suppl 1():14-22. PubMed ID: 2581383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound.
    Van Wauwe J; Awouters F; Neimegeers CJ; Janssens F; Van Nueten JM; Janssen PA
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):39-51. PubMed ID: 6114717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levocabastine: pharmacological profile of a highly effective inhibitor of allergic reactions.
    Awouters F; Niemegeers CJ; Jansen T; Megens AA; Janssen PA
    Agents Actions; 1992 Jan; 35(1-2):12-8. PubMed ID: 1354927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy.
    Richards DM; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Jul; 28(1):38-61. PubMed ID: 6204835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
    Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs.
    Kamei C; Mio M; Izushi K; Kitazumi K; Tsujimoto S; Fujisawa K; Adachi Y; Tasaka K
    Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the specific histamine H1-antagonist astemizole.
    Awouters FH; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1983; 33(3):381-8. PubMed ID: 6135428
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [General review of a non-sedative antihistaminic, astemizole (Hismanal), a H1 receptor antagonist].
    Molkhou P
    Allerg Immunol (Paris); 1988 May; 20(5):197-201. PubMed ID: 2900641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a new antihistamine: astemizole.
    Ray JA
    N Engl Reg Allergy Proc; 1985; 6(1):71-7. PubMed ID: 2888010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chlorpheniramine, pyrilamine and astemizole on intracranial self-stimulation in rats.
    Wauquier A; Niemegeers CJ
    Eur J Pharmacol; 1981 Jun; 72(2-3):245-8. PubMed ID: 6113975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of interaction between the H1-antagonist astemizole and other drugs.
    Rombaut N; Heykants J; Vanden Bussche G
    Ann Allergy; 1986 Nov; 57(5):321-4. PubMed ID: 2877601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astemizole: a long-acting, nonsedating antihistamine.
    Krstenansky PM; Cluxton RJ
    Drug Intell Clin Pharm; 1987 Dec; 21(12):947-53. PubMed ID: 2892659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new H1-blocking antihistamine. Critical review of pharmacological and clinical studies].
    Emmi L; Rossi O
    Minerva Med; 1988 Mar; 79(3):219-27. PubMed ID: 2896316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Astemizole: its pharmacokinetics and pharmacologic properties].
    Levron JC; Gillardin JM; Sabbah A
    Allerg Immunol (Paris); 1990 Jun; 22(6):233-41. PubMed ID: 1974137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of allergic reactions by a new antiallergic drug, LC-6 (trans-2,3b,4,5,7,8b,9,10-octahydronaphthol[1,2-c:5,6-c'] dipyrazole). I. Inhibition of the rat reaginic passive cutaneous anaphylaxis.
    Hurtado I; Márquez VE; Vítolo MJ
    Int Arch Allergy Appl Immunol; 1978; 57(6):507-13. PubMed ID: 28295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astemizole and other H1-antihistaminic drug treatment of asthma.
    Holgate ST; Emanuel MB; Howarth PH
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):375-80. PubMed ID: 2862178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.